Press Releases
MAR 24, 2026
Oxford spinout Stateful Robotics raises $4.8m to bring long-horizon intelligence to real-world robotics
Press Releases
MAR 20, 2026
Plans for 100,000 sq ft lab space at 1-12 Magdalen Street approved
Press Releases
MAR 16, 2026
Densix raises $4m seed round to redefine power density for AI data centres and power grids
Press Releases
MAR 10, 2026
OSE announces new board appointments
Press Releases
JAN 07, 2026
Dark Blue Therapeutics acquired in deal worth up to $840m
Media Coverage
DEC 04, 2025
Advice for founders from Sam Harman, OSE Partner & Head of Deep Tech – Entrepreneur.com
Media Coverage
DEC 04, 2025
Advice for founders from Heather Roxborough, OSE Senior Partner & Head of HealthTech – Entrepreneur.com
Media Coverage
DEC 04, 2025
Advice for founders from Katya Smirnyagina, OSE Senior Partner for Life Sciences – Entrepreneur.com
Press Releases
NOV 19, 2025
Oxford Science Enterprises appoints Venetia Jennings as latest Deep Tech Entrepreneur-in-Residence
Thought Leadership
NOV 04, 2025
Why we invested in Kneu Health
Press Releases
OCT 30, 2025
Oxford Science Enterprises welcomes James Finlayson as Deep Tech Entrepreneur-in-Residence
Press Releases
OCT 16, 2025
OSE and Ellison Institute of Technology make first co-investment in $60m Series A for Wild Bioscience, to boost global agricultural resilience
Thought Leadership
OCT 01, 2025
Our new brand identity to support the next stage of growth – Ed Bussey, CEO
Press Releases
SEP 10, 2025
Oxford Science Enterprises welcomes Benny Axt as HealthTech Entrepreneur-in-Residence
Thought Leadership
AUG 08, 2025
The UK’s new industrial strategy and the future economy – Ed Bussey, CEO, LinkedIn
Press Releases
AUG 07, 2025
Oxford Science Enterprises partners with Tokyu Land to connect Oxford spinouts with Japan’s innovation ecosystem
Thought Leadership
JUL 21, 2025
How regional clusters can power the UK’s quantum revolution – Sam Harman, Head of Deep Tech, IOT World Today
Press Releases
JUN 09, 2025
Oxford Ionics reaches agreement to be acquired by IonQ for $1.075 billion
Media Coverage
JUN 03, 2025
Solving the greatest problem holding back UK tech – Ed Bussey, CEO, UKTN Podcast
Press Releases
APR 17, 2025
Oxford university VC firm OSE raises $232m from banks
Thought Leadership
APR 16, 2025
Speed, scale & sovereignty: UK tech’s defence opportunity – Ed Bussey, CEO, UKTN
Press Releases
APR 15, 2025
Oxford Science Enterprises welcomes Harry Clifford as HealthTech Entrepreneur-in-Residence
Media Coverage
APR 14, 2025
Start-ups: from campus to commerce, BBC Business Daily
Thought Leadership
MAR 26, 2025
Why university spinouts are an attractive asset class for pension funds – Ed Bussey, CEO, LinkedIn
Press Releases
MAR 25, 2025
Oxford University ranked #1 in UK spinout rankings, 2025 report
Press Releases
MAR 20, 2025
Oxford Science Enterprises welcomes Mark Chadwick as Deep Tech Scientist-in-Residence
Press Releases
MAR 17, 2025
Aviva injects £15m into Oxford Science Enterprises in boost for spinouts
Media Coverage
MAR 08, 2025
Oxford scale-ups want to upgrade the world, Wired
Press Releases
JAN 29, 2025
Oxford Science Enterprises and Cedars-Sinai announce partnership and first co-investment in neurology care company Neu Health
Press Releases
JAN 27, 2025
Oxford Science Enterprises welcomes Karandeep Bhogal as Deep Tech Entrepreneur-in-Residence
Media Coverage
JAN 08, 2025
Lunch With The Times: We’re building companies that are going to change the world – Ed Bussey, CEO, The Times
Press Releases
OCT 09, 2024
Oxford University ranked #1 globally for ninth consecutive year
Press Releases
JUL 16, 2024
Oxford Semantic Technologies to be acquired by Samsung Electronics
Thought Leadership
JUL 05, 2024
Science innovation must be at the heart of government action – Ed Bussey, CEO, The Times Commentary
Press Releases
JUN 19, 2024
Oxford Science Enterprises welcomes Professor Dame Fiona Murray and Professor Sir Peter Donnelly as Non-Executive Directors
Press Releases
MAY 22, 2024
Oxford Science Enterprises announces partnership with The Crown Estate and Pioneer Group
Press Releases
APR 17, 2024
Oxford Science Enterprises welcomes Kirsty Lloyd-Jukes as Deep Tech Entrepreneur-in-Residence
Press Releases
NOV 17, 2023
Oxford Science Enterprises welcomes UK Treasury’s review of university spinouts
Press Releases
NOV 01, 2023
Oxford Science Enterprises strengthens HealthTech team with two new Entrepreneurs-in-Residence
Press Releases
OCT 23, 2023
Oxford Science Enterprises supports launch of Oxford–Harrington Rare Disease Therapeutics Accelerator
Press Releases
AUG 31, 2023
Oxford Science Enterprises welcomes Ed Bussey as Chief Executive Officer
Press Releases
JUN 21, 2023
Oxford Science Enterprises and PHTA join forces to support early-stage startups
Press Releases
APR 21, 2023
Oxford Science Enterprises partners with leading universities and investors to launch USIT Guide
Press Releases
DEC 13, 2022
OxfordVR to combine with BehaVR to tackle global mental health crisis with evidence-based digital therapeutics
Press Releases
OCT 20, 2022
DJS Antibodies to be acquired by AbbVie
Press Releases
AUG 03, 2022
MiroBio to be acquired by Gilead Sciences for approximately $405 million
Press Releases
JUL 18, 2022
Oxford Science Enterprises raises £250 million
Press Releases
APR 03, 2022
Oxford ranked UK’s leading university for spinout creation; Oxford Science Enterprises named most active fund focused on a single university
Press Releases
NOV 23, 2020
Oxford COVID-19 vaccine, co-invented by Vaccitech, achieves breakthrough
Press Releases
OCT 27, 2020
Base Genomics acquired by Exact Sciences for $410m
Oxford researchers & innovators
Working on cutting-edge research? Let’s explore its potential together.
Start the conversationWORK WITH US
Oxford researchers & innovators
Want your research to have real-world impact?
We partner with researchers and innovators across Oxford, Harwell and Culham to explore commercial potential, co-create ventures and build companies.
Investors
Interested in becoming an OSE shareholder?
We’ve raised over £850m from global investors keen to access Oxford’s diverse, world-leading science. Our shareholders don’t just back OSE – many also co-invest alongside us.
Co-investors
Looking to invest in Oxford’s most exciting companies?
We partner with specialist global investors to fund and scale our companies – from pre-seed to growth. Together, OSE and our co-investors have invested more than £3bn.